The engineered zinc-finger protein transcription factors (ZFP TFs) are designed to fuse the human GM-CSF gene regulatory region to upregulate the expression of GM-CSF inserted in ONYX-411 for cancer treatment (237). This evidence concerns the gene CSF2 and cancer.